Report Detail

Pharma & Healthcare CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Poland

  • RnM3967975
  • |
  • 14 May, 2020
  • |
  • Poland
  • |
  • 162 Pages
  • |
  • GlobalData
  • |
  • Pharma & Healthcare

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Poland

Summary

GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Poland”. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in the Poland. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of the Poland. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

The Poland healthcare market is one of the major emerging markets in Central Europe, with a strong focus on healthcare reforms and R&D. The pharmaceutical market of Poland increased from €6.34B in 2011 to €7.54B in 2017 at a Compound Annual Growth Rate (CAGR) of 2.92%. However, in terms of USD, the pharmaceutical market decreased from $8.82B in 2011 to $8.52B in 2017, at a negative CAGR of 0.57%. The Poland medical devices market was valued at $2.79B in 2015, which increased at a CAGR of 4% to reach $3.27B in 2019.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in the Poland, and includes -
- An overview of the pharmaceutical markets, comprising market size, segmentation, COVID-19 epidemiology and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market (Novartis, GSK, Sanofi, Teva and PolPharma)
- Profiles and SWOT analyses of the major players in the medical device market (Abbott, Medtronic, GE Healthcare, Stryker, and Mercator Medical)
- Detailed analysis about recent completed deals in the pharmaceutical and medical device market of Poland
- Information regarding the health-tech landscape of the country along with the major health-tech deals
- An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
- Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
- An overview of the opportunities and challenges to growth in the Polish healthcare market

Reasons to Buy

This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving the Polish healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analysing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
- Identify, understand, and capitalize on the opportunities and challenges in the Polish healthcare market


Table of Contents

  • 1.1 List of Figures
  • 1.2 List of Tables

2 Executive Summary

  • 2.1 Executive Summary - Overview
  • 2.2 Key Highlights
  • 2.3 Key Highlights: Healthcare Start-Ups in Poland
  • 2.4 Key Events: Poland Pharmaceutical Timeline, 2014-2020
  • 2.5 Key Events: Poland Pharmaceutical Market
  • 2.6 Key Events: M&A, VF & PE Deals, Global Pharmaceutical Market, 2019-2020
  • 2.7 Key Events: Mergers and Acquisitions
  • 2.8 Country Profile, Poland, 2019

3 Overview of Pharmaceutical Market

  • 3.1 Pharmaceutical Market - Overview
  • 3.2 Pharmaceutical Market - Exports
  • 3.3 Pharmaceutical Market - Imports
  • 3.4 Pharmaceutical Market - Supply Channels
  • 3.5 Pharmaceutical Market - Market Segments
  • 3.6 Pharmaceutical Market - COVID-19 Epidemiology
    • 3.6.1 Pharmaceutical Market- Government Response to Mitigate COVID-19 Impact
    • 3.6.2 Pharmaceutical Market- COVID-19 Impact and Developments in Healthcare Market
  • 3.7 Pharmaceutical Market - Major Players

4 Overview of Medical Device Market

  • 4.1 Medical Device Market - Overview
  • 4.2 Medical Devices Market - Major Segments
    • 4.2.1 Medical Devices Market - Cardiovascular Devices
    • 4.2.2 Medical Devices Market - Ophthalmic Devices
    • 4.2.3 Medical Devices Market - Hospital Supplies Devices
    • 4.2.4 Medical Devices Market - Orthopedic Devices
    • 4.2.5 Medical Devices Market - Diagnostic Imaging
  • 4.3 Medical Devices Market - Diagnostics Market
  • 4.4 Medical Devices Market - Major Players

5 Pharmaceutical and Medical Device Market - Drivers and Barriers

  • 5.1 Drivers
  • 5.2 Barriers

6 Deal analysis

  • 6.1 Deal Analysis: M&A, VF and PE Deals, Pharmaceutical Market, Poland, 2019-2020
  • 6.2 Deal Analysis: M&A, VC, and PE Deals, Medical Devices Market, Poland, 2019-2020

7 HealthTech Landscape

  • 7.1 HealthTech Deals Landscape, Poland
    • 7.1.1 Key HealthTech Deals, Poland
    • 7.1.2 Digital Health Companies, Poland
  • 7.2 Adoption of Technology in Healthcare, Poland
    • 7.2.1 Healthcare Funding Covering the Use of Technology, Poland
    • 7.2.2 Government eHealth Initiative, Poland
    • 7.2.3 Regulatory Scenario Covering Use of Technology in Healthcare, Poland
  • 7.3 HealthTech Landscape- Poland- Benefits and Risks

8 Market Access

  • 8.1 Overview of Healthcare System, Poland
  • 8.2 Reimbursement Process, Poland
    • 8.2.1 Overview of Insurance Providers, Public Insurance, Poland
    • 8.2.2 Overview of Insurance Providers, Private Insurance, Poland
  • 8.3 Overview of Health Insurance, Poland
    • 8.3.1 Healthcare Spending and Health Price Index, Poland
    • 8.3.2 Pricing Policies, Poland
  • 8.4 Regulatory Landscape, Poland
    • 8.4.1 Overview of Regulatory Agencies
    • 8.4.2 Market Authorization for Pharmaceutical Products, National Procedure, Poland
    • 8.4.3 Market Authorization for Pharmaceutical Products, Centralized Procedure, Poland
    • 8.4.4 Market Authorization for Pharmaceutical Products, Decentralized Procedure, Poland
    • 8.4.5 Market Authorization for Pharmaceutical Products, Mutual Recognition Procedure, Poland
    • 8.4.6 Market Authorization for Generics and Biosimilars, Poland
    • 8.4.7 Market Authorization for Medical Devices, Poland
    • 8.4.8 Licensing Process for Pharmaceutical and Medical Device Manufacturing, Poland
    • 8.4.9 Licensing Process for Pharmaceutical Exports and Imports, Poland
      • 8.4.9.1 Parallel Import
    • 8.4.10 Intellectual Property Rights, Patent, Poland
      • 8.4.10.1 Intellectual Property Rights, European Patent, Poland
      • 8.4.10.2 Intellectual Property Rights, Unitary Patent, Poland
    • 8.4.11 Intellectual Property Rights, Trademark, Poland
    • 8.4.12 Clinical Trial Regulations, Poland
      • 8.4.12.1 Pharmaceutical Clinical Trials Landscape, Poland
      • 8.4.12.2 Medical Device Clinical Trials Landscape, Poland
    • 8.4.13 Pharmaceutical Advertising Regulations, Poland
    • 8.4.14 Labeling and Packaging Regulations, Poland

9 Country Healthcare Landscape

  • 9.1 Healthcare Policy Highlights
  • 9.2 Healthcare Facilities
  • 9.3 Healthcare Parameters
  • 9.4 Life Expectancy and Immunization Rate, Poland
  • 9.5 Environmental Health
  • 9.6 Healthcare Personnel
  • 9.7 Disease Burden
  • 9.8 Healthcare Expenditure

10 Trade Associations, Poland

    11 Trade Fairs, Poland

      12 Opportunities and Challenges

        13 Appendix

        • 13.1 Research Methodology
          • 13.1.1 Coverage
          • 13.1.2 Secondary Research
          • 13.1.3 Forecasts
          • 13.1.4 Expert Panel
        • 13.2 Bibliography
        • 13.3 Contact Us

        Summary:
        Get latest Market Research Reports on CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Poland. Industry analysis & Market Report on CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Poland is a syndicated market report, published as CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Poland. It is complete Research Study and Industry Analysis of CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Poland market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $1,995.00
        $3,990.00
        $5,985.00
        1,590.02
        3,180.03
        4,770.05
        1,853.36
        3,706.71
        5,560.07
        305,693.85
        611,387.70
        917,081.55
        166,462.80
        332,925.60
        499,388.40
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report